Attached files
| file | filename |
|---|---|
| 8-K - 8-K - NEXTGEN HEALTHCARE, INC. | q3fy20178-kpressrelease.htm |
For Further Information, Contact:
Quality Systems, Inc.
18111 Von Karman Avenue, Suite 800
Irvine, CA 92612
Phone: (949) 255-2600
Jamie Arnold, Chief Financial Officer
JArnold@nextgen.com
FOR IMMEDIATE RELEASE
January 25, 2017
Quality Systems, Inc. Reports Fiscal 2017 Third Quarter Results
IRVINE, Calif. - (January 25, 2017) - Quality Systems, Inc. (NASDAQ: QSII) announced today results for its fiscal 2017 third quarter ended December 31, 2016.
“We’ve seen a number of promising trends throughout the business this year, and I’m pleased with our fiscal third quarter results, as well as with the continued progress we’re making on our strategic initiatives. In addition to improving our customer attrition rates, we’ve also made great strides in customer satisfaction over the last several quarters. During the first 75 days since our new software release, we’ve seen significant interest and already have nearly 500 customers signed up to upgrade,” commented Rusty Frantz, president and chief executive officer of Quality Systems, Inc.
Mr. Frantz continued, “Through our restructuring, we’ve also identified meaningful RCM and EDI cross-selling opportunities within our existing customer base and hope to capitalize on them through the efforts of our newly reinvigorated salesforce. That said, given the uncertainty surrounding the ACA and the lengthy RCM sales cycle, we believe it will take some time before new bookings translate into top line growth. At this point in the year, I remain confident in delivering on the commitments we made in July.”
Revenues for the fiscal 2017 third quarter of $127.9 million compared to $117.0 million a year-ago. On a GAAP basis, net income for the 2017 third quarter was $10.5 million, compared with net income of $7.3 million in the 2016 third quarter. Non-GAAP net income for the 2017 third quarter was $14.4 million compared with non-GAAP net income of $10.0 million in the 2016 third quarter.
On a GAAP basis, fully diluted earnings per share was $0.17 in the fiscal 2017 third quarter compared with $0.12 earnings per share for the same period a year ago. On a non-GAAP basis, fully diluted earnings per share for the fiscal 2017 third quarter was $0.23 versus $0.16 reported in the third quarter a year ago.
Conference Call Information
Quality Systems will host a conference call to discuss its fiscal 2017 third quarter results on Wednesday, January 25, 2017 at 5:00 PM ET (2:00 PM PT). Shareholders and interested participants may listen to a live broadcast of the conference call by dialing 866-900-9499 or 937-502-2136 for international callers, and referencing participant code 56791651 approximately 15 minutes prior to the call. A live webcast of the conference call will be available on the investor relations section of the company’s web site and an audio file of the call will also be archived for 90 days at investor.qsii.com. After the conference call, a replay will be available until February 1, 2017 and can be accessed by dialing 800-585-8367 or 404-537-3406 for international callers, and referencing participant code 56791651.
About Quality Systems, Inc.
Irvine, Calif.-based Quality Systems, Inc. (QSI) and its subsidiary, NextGen Healthcare Information Systems, develop and provide a range of software and services for medical and dental group practices, including practice management and electronic health record applications, patient portal, interoperability and connectivity products, and population health management and analytics offerings. Services include managed cloud services, revenue cycle management, claims clearinghouse, data interchange and value-add consulting. The Company's solution portfolio is readily integrated and collectively positioned to drive low total cost of ownership for its client partners, as well as enable the transition to value-based healthcare. Visit www.qsii.com and www.nextgen.com for additional information.
Investor Contact:
Bob East or Asher Dewhurst
Westwicke Partners
443-213-0500
SAFE HARBOR PROVISIONS FOR FORWARD-LOOKING STATEMENTS
This news release may contain forward-looking statements within the meaning of the federal securities laws, including but not limited to, statements regarding future events, developments in the healthcare sector and regulatory framework, the Company's future performance, as well as management's expectations, beliefs, intentions, plans, estimates or projections relating to the future (including, without limitation, statements concerning revenue, net income, and earnings per share). Risks and uncertainties exist that may cause the results to differ materially from those set forth in these forward-looking statements. Factors that could cause the anticipated results to differ from those described in the forward-looking statements and additional risks and uncertainties are set forth in Part I, Item A of our most recent Annual Report on Form 10-K for the fiscal year ended March 31, 2016 and subsequently filed Quarterly Reports on Form 10-Q, including but not limited to: the volume and timing of systems sales and installations; length of sales cycles and the installation process; the possibility that products will not achieve or sustain market acceptance; seasonal patterns of sales and customer buying behavior; impact of incentive payments under The American Recovery and Reinvestment Act on sales and the ability of the Company to meet continued certification requirements; the development by competitors of new or superior technologies; the timing, cost and success or failure of new product and service introductions, development and product upgrade releases; undetected errors or bugs in software; product liability; changing economic, political or regulatory influences in the health-care industry; changes in product-pricing policies; availability of third-party products and components; competitive pressures including product offerings, pricing and promotional activities; the Company's ability or inability to attract and retain qualified personnel; possible regulation of the Company's software by the U.S. Food and Drug Administration; changes of accounting estimates and assumptions used to prepare the prior periods' financial statements; disruptions caused by acquisitions of companies, products, or technologies; and general economic conditions. A significant portion of the Company's quarterly sales of software product licenses and computer hardware is concluded in the last month of a fiscal quarter, generally with a concentration of such revenues earned in the final ten business days of that
month. Due to these and other factors, the Company's revenues and operating results are very difficult to forecast. A major portion of the Company's costs and expenses, such as personnel and facilities, are of a fixed nature and, accordingly, a shortfall or decline in quarterly and/or annual revenues typically results in lower profitability or losses. As a result, comparison of the Company's period-to-period financial performance is not necessarily meaningful and should not be relied upon as an indicator of future performance. These forward-looking statements speak only as of the date hereof. The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise.
USE OF NON-GAAP FINANCIAL MEASURES
This news release contains certain non-GAAP (Generally Accepted Accounting Principles) financial measures, which are provided only as supplemental information. Investors should consider these non-GAAP financial measures only in conjunction with the comparable GAAP financial measures. These non-GAAP measures are not in accordance with or a substitute for U.S. GAAP. Pursuant to the requirements of Regulation G, the Company has provided a reconciliation of non-GAAP financial measures to the most directly comparable financial measure in the accompanying financial tables. Other companies may calculate non-GAAP measures differently than Quality Systems, which limits comparability between companies. The Company believes that its presentation of non-GAAP diluted earnings per share provides useful supplemental information to investors and management regarding the Company's financial condition and results. The presentation of non-GAAP financial information is not intended to be considered in isolation or as a substitute for, or superior to, financial information prepared and presented in accordance with GAAP. The Company calculates non-GAAP diluted earnings per share by excluding net acquisition and disposition costs, amortization of acquired intangible assets, amortization of deferred debt issuance costs, loss on disposition, restructuring costs, net securities litigation defense costs, share-based compensation, and other non-run-rate expenses from GAAP income before provision for income taxes. The Company utilizes a normalized non-GAAP tax rate to provide better consistency across the interim reporting periods within a given fiscal year by eliminating the effects of non-recurring and period-specific items, which can vary in size and frequency, and which are not necessarily reflective of the Company’s longer-term operations. The normalized non-GAAP tax rate applied to each quarter of fiscal year 2016 and expected to be applied for each quarter of fiscal year 2017 period is 30.5%. The determination of this rate is based on the consideration of both historic and projected financial results. The Company intends to re-evaluate this normalized non-GAAP tax rate on an annual basis or more frequently if any significant events occur that may materially affect this rate, such as merger and acquisition activity, changes in business outlook, or changes in expectations regarding tax regulations.
The Company’s future period guidance in this release includes adjustments for items not indicative of the Company’s core operations. Such adjustments are generally expected to be of a nature similar to those adjustments applied to the Company’s historic GAAP financial results in the determination of the Company’s non-GAAP diluted earnings per share. Such adjustments, however, may be affected by changes in ongoing assumptions and judgments as to the items that are excluded in the calculation of non-GAAP adjusted net income and adjusted diluted earnings per share, as described in this release. The exact amount and probable significance of these adjustments, including net acquisition and disposition costs, net securities litigation defense costs, and other non-run-rate expenses, are not currently determinable without unreasonable efforts, but may be significant. These items cannot be reliably quantified or forecasted due to the combination of their historic and expected variability. It is therefore not practicable to reconcile this non-GAAP guidance to the most comparable GAAP measures.
FINANCIAL TABLES ATTACHED
QUALITY SYSTEMS, INC.
CONSOLIDATED STATEMENTS OF INCOME
(In thousands, except per share data)
(Unaudited)
Three Months Ended December 31, | Nine Months Ended December 31, | ||||||||||||||
2016 | 2015 | 2016 | 2015 | ||||||||||||
Revenues: | |||||||||||||||
Software license and hardware | $ | 16,995 | $ | 16,150 | $ | 48,966 | $ | 52,026 | |||||||
Software related subscription services | 22,546 | 11,705 | 63,911 | 36,388 | |||||||||||
Total software, hardware and related | 39,541 | 27,855 | 112,877 | 88,414 | |||||||||||
Support and maintenance | 39,924 | 39,519 | 116,905 | 125,408 | |||||||||||
Revenue cycle management and related services | 20,048 | 21,594 | 62,037 | 62,630 | |||||||||||
Electronic data interchange and data services | 21,790 | 20,643 | 65,527 | 61,413 | |||||||||||
Professional services | 6,565 | 7,421 | 19,893 | 26,700 | |||||||||||
Total revenues | 127,868 | 117,032 | 377,239 | 364,565 | |||||||||||
Cost of revenue: | |||||||||||||||
Software license and hardware | 5,680 | 6,530 | 19,227 | 20,149 | |||||||||||
Software related subscription services | 9,345 | 5,533 | 27,107 | 17,454 | |||||||||||
Total software, hardware and related | 15,025 | 12,063 | 46,334 | 37,603 | |||||||||||
Support and maintenance | 7,299 | 7,537 | 20,903 | 23,874 | |||||||||||
Revenue cycle management and related services | 13,462 | 14,381 | 42,052 | 43,573 | |||||||||||
Electronic data interchange and data services | 12,662 | 12,437 | 38,232 | 37,302 | |||||||||||
Professional services | 5,904 | 7,367 | 19,643 | 24,008 | |||||||||||
Total cost of revenue | 54,352 | 53,785 | 167,164 | 166,360 | |||||||||||
Gross profit | 73,516 | 63,247 | 210,075 | 198,205 | |||||||||||
Operating expenses: | |||||||||||||||
Selling, general and administrative | 37,542 | 39,395 | 120,913 | 115,962 | |||||||||||
Research and development costs, net | 19,714 | 14,518 | 56,230 | 49,584 | |||||||||||
Amortization of acquired intangible assets | 2,568 | 897 | 7,889 | 2,692 | |||||||||||
Restructuring costs | 231 | — | 4,685 | — | |||||||||||
Total operating expenses | 60,055 | 54,810 | 189,717 | 168,238 | |||||||||||
Income from operations | 13,461 | 8,437 | 20,358 | 29,967 | |||||||||||
Interest income | — | 60 | 9 | 406 | |||||||||||
Interest expense | (629 | ) | (11 | ) | (2,445 | ) | (14 | ) | |||||||
Other expense, net | (4 | ) | (43 | ) | (146 | ) | (147 | ) | |||||||
Income before provision for income taxes | 12,828 | 8,443 | 17,776 | 30,212 | |||||||||||
Provision for income taxes | 2,342 | 1,141 | 3,950 | 8,233 | |||||||||||
Net income | $ | 10,486 | $ | 7,302 | $ | 13,826 | $ | 21,979 | |||||||
Net income per share: | |||||||||||||||
Basic | $ | 0.17 | $ | 0.12 | $ | 0.22 | $ | 0.36 | |||||||
Diluted | $ | 0.17 | $ | 0.12 | $ | 0.22 | $ | 0.36 | |||||||
Weighted-average shares outstanding: | |||||||||||||||
Basic | 62,093 | 60,867 | 61,645 | 60,548 | |||||||||||
Diluted | 62,093 | 61,279 | 61,900 | 61,190 | |||||||||||
Dividends declared per common share | $ | — | $ | 0.175 | $ | — | $ | 0.525 | |||||||
QUALITY SYSTEMS, INC.
CONSOLIDATED BALANCE SHEETS
(In thousands, except per share data)
(Unaudited)
December 31, 2016 | March 31, 2016 | ||||||
ASSETS | |||||||
Current assets: | |||||||
Cash and cash equivalents | $ | 23,994 | $ | 27,176 | |||
Restricted cash and cash equivalents | 4,647 | 5,320 | |||||
Marketable securities | — | 9,297 | |||||
Accounts receivable, net | 75,516 | 94,024 | |||||
Inventory | 252 | 555 | |||||
Income taxes receivable | 14,481 | 32,709 | |||||
Prepaid expenses and other current assets | 15,944 | 14,910 | |||||
Total current assets | 134,834 | 183,991 | |||||
Equipment and improvements, net | 26,097 | 25,790 | |||||
Capitalized software costs, net | 12,995 | 13,250 | |||||
Deferred income taxes, net | 9,780 | 8,198 | |||||
Intangibles, net | 74,722 | 91,675 | |||||
Goodwill | 185,888 | 188,837 | |||||
Other assets | 18,703 | 19,049 | |||||
Total assets | $ | 463,019 | $ | 530,790 | |||
LIABILITIES AND SHAREHOLDERS’ EQUITY | |||||||
Current liabilities: | |||||||
Accounts payable | $ | 5,223 | $ | 11,126 | |||
Deferred revenue | 49,763 | 57,935 | |||||
Accrued compensation and related benefits | 18,620 | 18,670 | |||||
Income taxes payable | 8 | 91 | |||||
Other current liabilities | 44,338 | 50,238 | |||||
Total current liabilities | 117,952 | 138,060 | |||||
Deferred revenue, net of current | 1,312 | 1,335 | |||||
Deferred compensation | 6,738 | 6,357 | |||||
Line of credit | 25,000 | 105,000 | |||||
Other noncurrent liabilities | 14,267 | 10,661 | |||||
Total liabilities | 165,269 | 261,413 | |||||
Commitments and contingencies | |||||||
Shareholders' equity: | |||||||
Common stock | |||||||
$0.01 par value; authorized 100,000 shares; issued and outstanding 62,437 and 60,978 shares at December 31, 2016 and March 31, 2016, respectively | 624 | 610 | |||||
Additional paid-in capital | 225,967 | 211,262 | |||||
Accumulated other comprehensive loss | (653 | ) | (481 | ) | |||
Retained earnings | 71,812 | 57,986 | |||||
Total shareholders' equity | 297,750 | 269,377 | |||||
Total liabilities and shareholders' equity | $ | 463,019 | $ | 530,790 | |||
QUALITY SYSTEMS, INC.
NON-GAAP FINANCIAL MEASURES
(In thousands, except per share data)
RECONCILIATION OF NON-GAAP DILUTED EARNINGS PER SHARE
Three Months Ended December 31, | Nine Months Ended December 31, | ||||||||||||||
2016 | 2015 | 2016 | 2015 | ||||||||||||
Income before provision for income taxes - GAAP | $ | 12,828 | $ | 8,443 | $ | 17,776 | $ | 30,212 | |||||||
Non-GAAP adjustments: | |||||||||||||||
Acquisition and disposition costs, net | (1,337 | ) | 4,451 | 5,147 | 5,743 | ||||||||||
Amortization of acquired intangible assets | 5,575 | 1,800 | 16,953 | 5,402 | |||||||||||
Amortization of deferred debt issuance costs | 269 | — | 807 | — | |||||||||||
Loss on disposition of Hospital Solutions Division and related costs | — | 1,753 | — | 1,753 | |||||||||||
Restructuring costs | 231 | — | 4,685 | — | |||||||||||
Securities litigation defense costs, net of insurance | 356 | (3,075 | ) | 1,483 | (281 | ) | |||||||||
Share-based compensation | 2,001 | 743 | 5,067 | 2,328 | |||||||||||
Other non-run-rate expenses* | 739 | 335 | 2,865 | 1,722 | |||||||||||
Total adjustments to GAAP income before provision for income taxes: | 7,834 | 6,007 | 37,007 | 16,667 | |||||||||||
Income before provision for income taxes - Non-GAAP | 20,662 | 14,450 | 54,783 | 46,879 | |||||||||||
Provision for income taxes | 6,302 | 4,407 | 16,709 | 14,298 | |||||||||||
Net income - Non-GAAP | $ | 14,360 | $ | 10,043 | $ | 38,074 | $ | 32,581 | |||||||
Diluted net income per share - Non-GAAP | $ | 0.23 | $ | 0.16 | $ | 0.62 | $ | 0.53 | |||||||
Weighted-average shares outstanding (diluted): | 62,093 | 61,279 | 61,900 | 61,190 | |||||||||||
* For the three months ended December 31, 2016, other non-run-rate expenses consist primarily of professional services costs not related to core operations. Other non-run-rate expenses for the nine months ended December 31, 2016 consists primarily of professional services costs not related to core operations and $191 of executive hiring costs.
For the three months ended December 31, 2015, other non-run-rate expenses consists of non-recurring severance and other employee-related costs incurred in connection with the Hospital disposition. Other non-run-rate expenses for the nine months ended December 31, 2015 includes $449 in certain professional services costs not related to core operations, non-recurring severance and other employee-related costs incurred in connection with the Hospital disposition, and $938 of incremental costs related to the change in the Company's Chief Executive Officer, including recruitment fees and severance payments.